Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Arcutis Biotherapeutics, Inc. (ARQT)

31.97 +0.52 (+1.65%)
At close: 4:00:01 PM EDT
32.16 +0.19 (+0.58%)
After hours: 5:18:35 PM EDT
Trade ARQT on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
463,981
376,072
196,542
59,606
3,686
Cost of Revenue
41,096
36,695
19,128
4,987
754
Gross Profit
422,885
339,377
177,414
54,619
2,932
Operating Expense
388,632
351,604
305,811
295,720
304,559
Operating Income
34,253
-12,227
-128,397
-241,101
-301,627
Net Non Operating Interest Income Expense
-5,008
-3,186
-11,042
-17,195
-15,652
Other Income Expense
53
443
47
-731
5,821
Pretax Income
29,298
-14,970
-139,392
-259,027
-311,458
Tax Provision
779
1,171
647
3,113
0
Net Income Common Stockholders
28,519
-16,141
-140,039
-262,140
-311,458
Diluted NI Available to Com Stockholders
28,519
-16,141
-140,039
-262,140
-311,458
Basic EPS
0.22
-0.13
-1.16
-3.78
-5.66
Diluted EPS
0.22
-0.13
-1.16
-3.78
-5.66
Basic Average Shares
128,948.50
127,234
120,957.63
69,305.49
55,032.27
Diluted Average Shares
131,950
127,234
120,957.63
69,305.49
55,032.27
Total Operating Income as Reported
34,253
-12,227
-128,397
-241,101
-301,627
Total Expenses
429,728
388,299
324,939
300,707
305,313
Net Income from Continuing & Discontinued Operation
28,519
-16,141
-140,039
-262,140
-311,458
Normalized Income
28,519
-16,141
-140,039
-262,140
-311,458
Interest Income
8,838
8,897
16,126
12,517
--
Interest Expense
13,846
12,083
27,168
29,712
15,652
Net Interest Income
-5,008
-3,186
-11,042
-17,195
-15,652
EBIT
43,144
-2,887
-112,224
-229,315
-295,806
EBITDA
45,394
1,780
-110,265
-228,565
-294,872
Reconciled Cost of Revenue
41,096
36,695
19,128
4,987
754
Reconciled Depreciation
2,250
4,667
1,959
750
934
Net Income from Continuing Operation Net Minority Interest
28,519
-16,141
-140,039
-262,140
-311,458
Normalized EBITDA
45,394
1,780
-110,265
-228,565
-294,872
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 1/31/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: